Elmhurst Outpatient Surgery Center Offers Advanced Eye Pressure Treatment
Eyes and lungs wide, wide open seems to be the standard modus operandi for musicians who play instruments such as the trumpet, saxophone and trombone. But did you know that professional wind musicians could be at higher risk for developing ocular hypertension? It’s true, according to study published in Graefe's Archive for Clinical and Experimental Ophthalmology.
Unfortunately, ocular hypertension, or high eye pressure, can cause numerous vision problems. When pressure builds up in the eye, it can damage the optic nerve and result in the gradual loss of vision and could eventually lead to blindness. In addition, people with ocular hypertension are also considered “glaucoma suspects.”
Professional wind musicians, however, are not the only ones who have to worry about high eye pressure and the possibility of developing glaucoma. Indeed, the risk of developing ocular hypertension becomes much more common in anyone older than 40, in people of African-Caribbean origin and in diabetics.
Patients suffering from high eye pressure could control the condition with prescription eye drops. Unfortunately, studies have shown that more than 90% of patients do not comply with their ocular medication dosing regimens and nearly 50% discontinue taking their medications before 6 months.
“The eye drops used to treat glaucoma can be difficult to administer and expensive. This can be a serious problem. When pressure in the eye is out of control, it can increase the risk for permanent vision loss,” says Balaji Gupta, M.D.
The good news: Elmhurst Outpatient Surgery Center is offering an advanced treatment option for patients with ocular hypertension and cataracts. EOSC is one of the first facilities in Illinois to utilize the iStent® Trabecular Micro-Bypass Stent, produced by Glaukos Corp., Laguna Hills, Calif. The advanced technology is used in conjunction with cataract surgery to reduce eye pressure in adult patients with mild-to-moderate open-angle glaucoma currently being treated with glaucoma medicine. iStent is the smallest medical device ever approved by the FDA and does not significantly extend the length of time the patient spends in surgery. In clinical trials, iStent has been shown to safely reduce eye pressure, which is the primary cause of open-angle glaucoma.
“This is great news for people who have both a cataract and glaucoma,” says Dr. Gupta. “With iStent, many patients will need less medicine to control their eye pressure and some may not need prescription eye drops at all.”
About Elmhurst Outpatient Surgery Center
Elmhurst Outpatient Surgery Center is a multi-specialty center performing more than 8,000 procedures annually in Elmhurst. Elmhurst Outpatient Surgery Center has been serving the communities within DuPage, Cook, Will, Kane and other surrounding counties since 1999. For more information, visit www.eosc.org.